Zhang X Y, Tsuchiya N, Dohi M, Yamamoto K, Ishihara K, Okudaira H, Ito K, Miyamoto T
Department of Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, Japan.
Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 1):66-71. doi: 10.1016/0090-1229(92)90023-h.
MRL-lpr/lpr mice were treated with Tripterygium Wilfordii Hook-F (TWHF), a Chinese herbal medicine successfully used for human rheumatoid arthritis. Dramatic prolongation of survival and the reduction of urinary protein were observed in mice treated with a high dose of TWHF (20 mg/kg, three times a week) compared to the control animals receiving solvent alone. A slight but significant reduction was also seen in the degree of lymphadenopathy and arthritis with the high dose treatment. Surprisingly, no significant difference was present in IgM rheumatoid factor and IgG anti-double-stranded DNA antibody levels or in the histopathology of lupus nephritis. These results indicate the dissociation of histopathological renal disease and the degree of proteinuria or the life span. Although further pharmacological analysis is required, TWHF might be potentially useful for diseases such as systemic lupus erythematosus or nephrotic syndrome.
MRL-lpr/lpr小鼠接受了雷公藤(一种成功用于治疗人类类风湿性关节炎的中药)治疗。与仅接受溶剂的对照动物相比,高剂量雷公藤(20mg/kg,每周三次)治疗的小鼠生存期显著延长,尿蛋白减少。高剂量治疗还使淋巴结病和关节炎程度略有但显著降低。令人惊讶的是,IgM类风湿因子和IgG抗双链DNA抗体水平或狼疮性肾炎的组织病理学无显著差异。这些结果表明组织病理学肾病与蛋白尿程度或寿命之间存在分离。尽管需要进一步的药理学分析,但雷公藤可能对系统性红斑狼疮或肾病综合征等疾病有潜在的治疗作用。